PathAI

PathAI offers algorithms for pathology assessment across translational research, clinical development, and digital pathology.

Enhancing the discovery of novel biomarkers in MASH and other liver diseases with quantitative, cellular-level characterization of tissue and fibrosis microarchitecture in liver biopsies.

Unprecedented resolution of the tumor microenvironment (TME) from H&E whole slide images powered by AI

PathAI's company blog

Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

PathAI and MedStar Health Announce Partnership to Deploy the AISight Dx Digital Pathology Platform and Advanced AI Applications

PathAI Expands AISight Clinical Trials Platform with Launch of AIM-HI UC and IBDExploreTM for Standardized Histopathology Endpoints

PathAI's AIM-MASH AI Assist1 Becomes First AI-Powered Pathology Tool to Receive FDA Qualification for MASH Clinical Trials

The company works to address healthcare challenges and use artificial intelligence in pathology.

The company has a pathology network.

About PathAI

An AISight demo account is available by request.

Demo AI-powered pathology for oncology, liver & MASH, and IBD research solutions. Reveal Human Interpretable features for structured, standardized, and scalable analysis.

PathAI works with biopharma, laboratories, and clinicians on AI-powered pathology to improve patient outcomes.

PathAI uses cookies and similar tracking technologies when visitors interact with its websites and platforms, collectively called Platforms and Services.

PathAI privacy policy and notices

PathAI Terms of Use

GitHubRepository owner